Answer
No. It is a targeted tyrosine kinase inhibitor that blocks abnormal ALK signalling in susceptible cancer cells.
Sources for this answer
- Alecensa 150 mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.